Molecular determinants of the interactions between LXR/RXR heterodimers and TRAP220

Biochemical and Biophysical Research Communications

Volumn 384, Issue 3, 2009, Pages 389-393

  Son, You Lee ^a   Lee, Young Chul ^a  

^a Chonnam National University   (South Korea)

Author keywords

Allosteric activation; Liver X receptor; LXR RXR heterodimers; NR box (LXXLL motif); NR specificity; One plus two hybrid system; TRAP220 coactivator

Indexed keywords

CELL NUCLEUS RECEPTOR; FURYLFURAMIDE; HETERODIMER; LIVER X RECEPTOR; PROLINE; PROTEIN; RETINOID X RECEPTOR; TRAP220 PROTEIN; UNCLASSIFIED DRUG;

ALLOSTERISM; ARTICLE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; TWO HYBRID SYSTEM;

ANIMALS; DNA-BINDING PROTEINS; HUMANS; MICE; MUTATION; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RETINOID X RECEPTORS; SEQUENCE DELETION; TRANSCRIPTION FACTORS; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 65649131624     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.04.131     Document Type: Article

References (25)

1. Albers M., Blume B., Schlueter T., Wright M.B., Kober I., Kremoser C., Deuschle U., and Koegl M. A novel principle for partial agonism of liver X receptor ligands. Competitive recruitment of activators and repressors. J. Biol. Chem. 281 (2006) 4920-4930
2. Heery D.M., Kalkhoven E., Hoare S., and Parker M.G. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387 (1997) 733-736
3. Zelcer N., and Tontonoz P. Liver X receptors as integrators of metabolic and inflammatory signaling. J. Clin. Invest. 116 (2006) 607-614
4. Wiebel F.F., and Gustafsson J.A. Heterodimeric interaction between retinoid X receptor alpha and orphan nuclear receptor OR1 reveals dimerization-induced activation as a novel mechanism of nuclear receptor activation. Mol. Cell. Biol. 17 (1997) 3977-3986
5. Wiebel F.F., Steffensen K.R., Treuter E., Feltkamp D., and Gustafsson J.A. Ligand-independent coregulator recruitment by the triply activatable OR1/retinoid X receptor-alpha nuclear receptor heterodimer. Mol. Endocrinol. 13 (1999) 1105-1118
6. Huuskonen J., Fielding P.E., and Fielding C.J. Role of p160 coactivator complex in the activation of liver X receptor. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 703-708
7. A. IJpenberg, N.S. Tan, L. Gelman, S. Kersten, J. Seydoux, J. Xu, D. Metzger, L. Canaple, P. Chambon, W. Wahli, B. Desvergne, In vivo activation of PPAR target genes by RXR homodimers, EMBO J. 23 (2004) 2083-2091.
8. Waters L., Yue B., Veverka V., Renshaw P., Bramham J., Matsuda S., Frenkiel T., Kelly G., Muskett F., Carr M., and Heery D.M. Structural diversity in p160/CREB-binding protein coactivator complexes. J. Biol. Chem. 281 (2006) 14787-14795
9. Kim S.W., Park K., Kwak E., Choi E., Lee S., Ham J., Kang H., Kim J.M., Hwang S.Y., Kong Y.Y., Lee K., and Lee J.W. Activating signal cointegrator 2 required for liver lipid metabolism mediated by liver X receptors in mice. Mol. Cell. Biol. 23 (2003) 3583-3592
10. Laffitte B.A., Chao L.C., Li J., Walczak R., Hummasti S., Joseph S.B., Castrillo A., Wilpitz D.C., Mangelsdorf D.J., Collins J.L., Saez E., and Tontonoz P. Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc. Natl. Acad. Sci. USA 100 (2003) 5419-5424
11. Kawajiri K., Ikuta T., Suzuki T., Kusaka M., Muramatsu M., Fujieda K., Tachibana M., and Morohashi K. Role of the LXXLL-motif and activation function 2 domain in subcellular localization of Dax-1 (dosage-sensitive sex reversal-adrenal hypoplasia-congenita critical region on the X chromosome, gene 1). Mol. Endocrinol. 17 (2003) 994-1004
12. Kaneko E., Matsuda M., Yamada Y., Tachibana Y., Shimomura I., and Makishima M. Induction of intestinal ATP-binding cassette transporters by a phytosterol-derived liver X receptor agonist. J. Biol. Chem. 278 (2003) 36091-36098
13. Son Y.L., Park O.G., Kim G.S., Lee J.W., and Lee Y.C. RXR heterodimerization allosterically activates LXR binding to the second NR box of activating signal co-integrator-2. Biochem. J. 410 (2008) 319-330
14. Ito M., and Roeder R.G. The TRAP/SMCC/Mediator complex and thyroid hormone receptor function. Trends Endocrinol. Metab. 12 (2001) 127-134
15. Ren Y., Behre E., Ren Z., Zhang J., Wang Q., and Fondell J.D. Specific structural motifs determine TRAP220 interactions with nuclear hormone receptors. Mol. Cell. Biol. 20 (2000) 5433-5446
16. Kim J.Y., Park O.G., Lee J.W., and Lee Y.C. One- plus two-hybrid system, a novel yeast genetic selection for specific missense mutations disrupting protein/protein interactions. Mol. Cell. Proteomics 6 (2007) 1727-1740
17. Na S.Y., Choi J.E., Kim H.J., Jhun B.H., Lee Y.C., and Lee J.W. Bcl3, an IkappaB protein, stimulates activating protein-1 transactivation and cellular proliferation. J. Biol. Chem. 274 (1999) 28491-28496
18. Goo Y.H., Sohn Y.C., Kim D.H., Kim S.W., Kang M.J., Jung D.J., Kwak E., Barlev N.A., Berger S.L., Chow V.T., Roeder R.G., Azorsa D.O., Meltzer P.S., Suh P.G., Song E.J., Lee K.J., Lee Y.C., and Lee J.W. Activating signal cointegrator 2 belongs to a novel steady-state complex that contains a subset of trithorax group proteins. Mol. Cell. Biol. 23 (2003) 140-149
19. Coulthard V.H., Matsuda S., and Heery D.M. An extended LXXLL motif sequence determines the nuclear receptor binding specificity of TRAP220. J. Biol. Chem. 278 (2003) 10942-10951
20. Rachez C., Gamble M., Chang C.P., Atkins G.B., Lazar M.A., and Freedman L.P. The DRIP complex and SRC-1/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes. Mol. Cell. Biol. 20 (2000) 2718-2726
21. Nolte R.T., Wisely G.B., Westin S., Cobb J.E., Lambert M.H., Kurokawa R., Rosenfeld M.G., Willson T.M., Glass C.K., and Milburn M.V. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature 395 (1998) 137-143
22. Pogenberg V., Guichou J.F., Vivat-Hannah V., Kammerer S., Perez E., Germain P., de Lera A.R., Gronemeyer H., Royer C.A., and Bourguet W. Characterization of the interaction between retinoic acid receptor/retinoid X receptor (RAR/RXR) heterodimers and transcriptional coactivators through structural and fluorescence anisotropy studies. J. Biol. Chem. 280 (2005) 1625-1633
23. Gampe Jr. R.T., Montana V.G., Lambert M.H., Miller A.B., Bledsoe R.K., Milburn M.V., Kliewer S.A., Willson T.M., and Xu H.E. Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Mol. Cell 5 (2000) 545-555
24. Svensson S., Ostberg T., Jacobsson M., Norstrom C., Stefansson K., Hallen D., Johansson I.C., Zachrisson K., Ogg D., and Jendeberg L. Crystal structure of the heterodimeric complex of LXRalpha and RXRbeta ligand-binding domains in a fully agonistic conformation. EMBO J. 22 (2003) 4625-4633
25. Chang C., Norris J.D., Gron H., Paige L.A., Hamilton P.T., Kenan D.J., Fowlkes D., and McDonnell D.P. Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and beta. Mol. Cell. Biol. 19 (1999) 8226-8239